| ABC | ATP-Binding Cassette |
| ADC | Antibody Drug Conjugate |
| ADCC | Antibody Dependent Cellular Cytotoxicity |
| ADP | Adenosine Diphosphate |
| ALK | Activin Receptor-Like Kinase |
| ARC | Antibody Radioisotope Conjugate |
| CAR-T | Chimeric Antigen Receptor T Cell |
| CD | Cluster of Differentiation |
| CDC | Complement Dependent Cytotoxicity |
| CTLA | Cytotoxic T-Lymphocyte Associated Protein |
| EGFR | Epidermal Growth Factor Receptor |
| EpCAM | Epithelial Cell Adhesion Molecule |
| ERAD | Endoplasmic Reticulum-Associated Protein Degradation |
| FDA | Food and Drug Administration |
| Fv | Variable Fragment |
| GPC3 | Glypican-3 |
| HCC | Hepatocellular Carcinoma |
| IGF(R) | Insulin-Like Growth Factor (Receptor) |
| MHC | Major Histocompatibility Complex |
| MMAE | Monomethyl Auristatin E |
| Mono | Monoclonal |
| mPE24 | Mutated PE24 |
| mRNA | Messenger Ribonucleic Acid |
| NCI | National Cancer Institute |
| PDGFRA | Platelet-Derived Growth Factor Receptor Alpha Chain |
| PD-1 | Programmed Cell Death Protein 1 |
| PD-L1 | Programmed Cell Death Protein Ligand 1 |
| PEG | Polyethylene Glycol |
| PE38 | Pseudomonas Exotoxin A Domain II and Domain III |
| PGF | Placental Growth Factor |
| RIT | Recombinant Immunotoxin |
| TCR | T-Cell Receptor |
| VEGF(R) | Vascular Endothelial Growth Factor (Receptor) |
| VH | Heavy Chain Variable Region |